Howard University Center for Sickle Cell disease
1840 7th Street Northwest
Washington, District of Columbia 20001

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Howard University Center for Sickle Cell disease
mi
from
Washington DC,
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A Study of the Effect of IW-1701, a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Howard University Center for Sickle Cell disease
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Howard University Center for Sickle Cell disease
mi
from
Washington DC,
Click here to add this to my saved trials